To Compete With China, US FDA Must Deregulate Early Gene Therapy Studies, CAR-T Inventor Says

HHS Secretary Robert F. Kennedy Jr., CMS Administrator Mehmet Oz and NIH Director Jay Bhattacharya spoke at the FDA's 5 June cell and gene therapy panel. (Derrick Gingery)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Cell & Gene Therapies

More from Rare Diseases